130 related articles for article (PubMed ID: 37313919)
1. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract][Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative apocrine carcinoma as a rare cause of a breast lump in a Syrian female: a case report and review of the literature.
Ismail S; Kherbek H; Skef J; Zahlouk N; Abdulal R; Alshehabi Z
BMC Womens Health; 2021 Nov; 21(1):396. PubMed ID: 34823507
[TBL] [Abstract][Full Text] [Related]
4. Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.
Mills AM; E Gottlieb C; M Wendroth S; M Brenin C; Atkins KA
Am J Surg Pathol; 2016 Aug; 40(8):1109-16. PubMed ID: 27259012
[TBL] [Abstract][Full Text] [Related]
5. Apocrine carcinoma of the breast.
Yamazaki M; Nagata Y; Monji S; Shigematsu Y; Baba T; Shimokawa H; Uramoto H; Yamada S; Hanagiri T; Tanaka F
J UOEH; 2011 Dec; 33(4):293-301. PubMed ID: 22259834
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
[TBL] [Abstract][Full Text] [Related]
7. AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers.
Lerner G; Tang H; Singh K; Golestani R; St Claire S; Humphrey PA; Lannin D; Janostiak R; Harigopal M
Clin Breast Cancer; 2023 Feb; 23(2):199-210. PubMed ID: 36577560
[TBL] [Abstract][Full Text] [Related]
8. Breast Apocrine Carcinoma Detected Incidentally as Axillary Lymphadenopathy in a CT Scan.
Barron M; Asaad A; Idaewor P; Rasheed N; Saad Abdalla Al-Zawi A
Cureus; 2021 Oct; 13(10):e18523. PubMed ID: 34754678
[TBL] [Abstract][Full Text] [Related]
9. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
10. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.
Vranic S; Tawfik O; Palazzo J; Bilalovic N; Eyzaguirre E; Lee LM; Adegboyega P; Hagenkord J; Gatalica Z
Mod Pathol; 2010 May; 23(5):644-53. PubMed ID: 20208479
[TBL] [Abstract][Full Text] [Related]
11. A Case Report on Apocrine Encapsulated Papillary Carcinoma of the Breast with Frank Invasion: A Diagnostic Quandary.
Taniguchi K; Yamasaki R; Kajiwara Y; Ichimura K; Yoshino T
Int J Surg Pathol; 2022 Dec; 30(8):939-944. PubMed ID: 35491656
[TBL] [Abstract][Full Text] [Related]
12. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report.
Yang P; Peng SJ; Dong YM; Yang L; Yang ZY; Hu XE; Bao GQ
World J Clin Cases; 2020 Dec; 8(23):6036-6042. PubMed ID: 33344602
[TBL] [Abstract][Full Text] [Related]
14. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.
Gromov P; Espinoza JA; Talman ML; Honma N; Kroman N; Timmermans Wielenga V; Moreira JM; Gromova I
PLoS One; 2014; 9(11):e112024. PubMed ID: 25389781
[TBL] [Abstract][Full Text] [Related]
15. An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
Vranic S; Gatalica Z
Clin Breast Cancer; 2022 Jun; 22(4):e576-e585. PubMed ID: 35027319
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M
Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers.
Choi J; Jung WH; Koo JS
Histol Histopathol; 2012 Nov; 27(11):1481-93. PubMed ID: 23018247
[TBL] [Abstract][Full Text] [Related]
19. A rare case of apocrine carcinoma of the breast: Cytopathological and immunohistopathological study.
Khandeparkar SG; Deshmukh SD; Bhayekar PD
J Cytol; 2014 Apr; 31(2):96-8. PubMed ID: 25210239
[TBL] [Abstract][Full Text] [Related]
20. Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast.
D'Arcy C; Quinn CM
J Clin Pathol; 2019 Jan; 72(1):7-11. PubMed ID: 30425121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
